MedScout

MedScout

Private
Austin, TexasHealthcare & Life Scienceshttps://www.medscout.io

Last Round

Growth Equity

Feb 25, 2026

Total Funding Raised

$20.8M

Momentum Score

25 /100

Company Overview

MedScout is a life sciences technology company that offers sales enablement software to facilitate a data-driven sales cycle, providing insights on affiliations, patient demographics, procedure volumes, referrals, and payment data to enhance market analysis, strategy development, and sales execution for improved operational productivity and growth.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Sales Enablement, Healthcare Analytics, Business Intelligence

Business Model

B2B

Customer Profile

Subscription SaaS, Data as a Service, Services & Consulting

AI Layer

Application

Keywords

revenue acceleration platformmedical claims dataMedTech salessales intelligencesales enablementterritory planningrevenue intelligencephysician targetinghealthcare analyticsCRM integrationvertical SaaSgo-to-market platformcommercial intelligencemedical device salesGTM platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MedScout Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MedScout Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Growth EquityFeb 25, 2026
Series AJul 26, 2024
SeedJun 28, 2023
Pre SeedJun 9, 2021

Key People

Founding team and executive leadership

Skylar Talley

Co-Founder, CEO

Founding Team

MedScout Investors

Notable investors and investment history

InvestorRounds
Stage 2 CapitalGrowth Equity, Series A, Seed
LiveOak VenturesGrowth Equity, Series A
Alumni VenturesSeed
Fulcrum Equity PartnersGrowth Equity, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 25, 2026

    $10M raised in a Growth Equity round.

  • Feb 25, 2026

    Launched Strategies, featuring AI agents for sales territory planning.

MedScout Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MedScout Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MedScout's valuation, stock price, and market status.

Firmographic Details

HeadquartersAustin, Texas
Employee Range49
Year Founded2020
Last FundingFeb 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.